ALK, ROS1, and RET - Does the Partner Gene Matter?

被引：0
|
作者：
Lovly, Christine [1 ]
Childress, Merrida [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
RET; ros1; NTRK1; ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MS22.02
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [41] Lonely Driver ROS1
    Savic, Spasenija
    Rothschild, Sacha
    Bubendorf, Lukas
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (05) : 776 - 777
  • [42] From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?
    Plodkowski, Andrew J.
    Drilon, Alexander
    Halpenny, Darragh F.
    O'Driscoll, Dearbhail
    Blair, Donald
    Litvak, Anya M.
    Zheng, Junting
    Moskowitz, Chaya S.
    Ginsberg, Michelle S.
    LUNG CANCER, 2015, 90 (02) : 321 - 325
  • [43] CLINICAL AND PROGNOSTIC IMPLICATION OF ALK AND ROS1 REARRANGEMENT IN NEVER SMOKER WITH SURGICALLY RESECTED LUNG ADENOCARCINOMA
    Kim, Hye Ryun
    Kim, Min Hwan
    Lim, Sun-Min
    Kim, Eun Young
    Park, Ji Soo
    Kim, Joo Hang
    Shim, Hyo Sup
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1220 - S1220
  • [44] Clinical Activity and Safety of the ALK/ROS1 TK Inhibitor PF-06463922 in Advanced NSCLC
    Bauer, T. M.
    Solomon, Benjamin J.
    Besse, Benjamin
    Navarro, A.
    James, L.
    Clancy, J.
    Mugundu, G.
    Martini, J. F.
    Abbattista, A.
    Shaw, A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S239 - S239
  • [45] Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer
    Clark, Jeffrey W.
    Camidge, D. Ross
    Kwak, Eunice L.
    Maki, Robert G.
    Shapiro, Geoffrey I.
    Chen, Isan
    Tan, Weiwei
    Randolph, Sophia
    Christensen, James G.
    Ozeck, Mark
    Tang, Yiyun
    Wilner, Keith D.
    Salgia, Ravi
    FUTURE ONCOLOGY, 2020, 16 (01) : 4289 - 4301
  • [46] Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
    Lin, Jessica J.
    Langenbucher, Adam
    Gupta, Pranav
    Yoda, Satoshi
    Fetter, Isobel J.
    Rooney, Marguerite
    Do, Andrew
    Kem, Marina
    Chang, Kylie Prutisto
    Oh, Audris Y.
    Chin, Emily
    Juric, Dejan
    Corcoran, Ryan B.
    Dagogo-Jack, Ibiayi
    Gainor, Justin F.
    Stone, James R.
    Lennerz, Jochen K.
    Lawrence, Michael S.
    Hata, Aaron N.
    Mino-Kenudson, Mari
    Shaw, Alice T.
    NPJ PRECISION ONCOLOGY, 2020, 4 (01)
  • [47] GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
    Peled, N.
    Gillis, R.
    Kilickap, S.
    Froesch, P.
    Orlov, S.
    Filippova, E.
    Demirci, U.
    Christopoulos, P.
    Cicin, I.
    Basal, F. Bugdayci
    Yilmaz, C.
    Fedor, M.
    Korkmaz, T.
    Paydas, S.
    Gautschi, O.
    Zirtiloglu, A.
    Eralp, Y.
    Cinkir, H. Y.
    Sezer, A.
    Erman, M.
    Tural, D.
    Turna, H. Z.
    Mazieres, J.
    Dudnik, E.
    Reguart, N.
    Camidge, R.
    Ng, T. L.
    Senler, F. Cay
    Beypinar, I.
    Yazilitas, D.
    Demirkazik, A.
    Karaoglu, A.
    Okutur, K.
    Coskun, H. Senol
    Sendur, M. A. Nahit
    Isikdogan, A.
    Cabuk, D.
    Yumuk, P. F.
    Yildiz, I.
    Kaplan, M. A.
    Ozyilkan, O.
    Oztop, I.
    Olmez, O. F.
    Aydin, K.
    Aydiner, A.
    Meydan, N.
    Grinberg, R.
    Roisman, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S656 - S656
  • [48] Inflammatory Myofibroblastic Tumor With ROS1 Gene Fusions in Children and Young Adolescents
    Schoot, Reineke A.
    Orbach, Daniel
    Minard Colin, Veronique
    Alaggio, Rita
    Di Carlo, Daniela
    Corradini, Nadege
    Mercolini, Federico
    Milano, Giuseppe Maria
    van Noesel, Max M.
    Rome, Angelique
    Dall'Igna, Patrizia
    Pajtler, Kristian
    Sparber-Sauer, Monika
    Ferrari, Andrea
    Casanova, Michela
    JCO PRECISION ONCOLOGY, 2023, 7
  • [49] Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations
    Chu, Ying-Hsia
    Barbee, Jada
    Yang, Soo-Ryum
    Chang, Jason C.
    Liang, Priscilla
    Mullaney, Kerry
    Chan, Roger
    Salazar, Paulo
    Benayed, Ryma
    Offin, Michael
    Drilon, Alexander
    Ladanyi, Marc
    Nafa, Khedoudja
    Arcila, Maria E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (06) : 642 - 654
  • [50] ALK and ROS1 Rearrangements, Coexistence and Treatment in EGFRWild Type Lung Adenocarcinoma - A Multicenter Study of 732 Cases
    Song, Zhengbo
    Zheng, Yuhui
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1160 - S1161
12345